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Mesothelioma is a rare tumour and its radiological growth pattern varies. We report the case of a biopsy
proven Malignant Pleural Mesothelioma (MPM) presenting as an anterior mediastinal mass in a platinum
miner. The prognosis for this aggressive tumour remains poor, despite combination treatment
modalities.
 2014 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.Introduction
MPM presenting as a mediastinal mass is rare. Malignant me-
sothelioma is manifested in four ways; irregular pleural thickening,
pleural effusion, lung encasement by tumour rind and parenchymal
nodular lesions at the periphery (Table 1) [1]. Asbestos exposure
and less commonly simian virus 40 are associated as causes of
malignant mesothelioma [2]. MPM presenting as an anterior
mediastenal mass is not well described in the literature.
Case report
A 56 year old non-smoker male, with a more than 25 year
occupational history of platinum mining, presented with unre-
lenting chest pain that was neither ischaemic nor pleuritic in na-
ture. He had a history of progressive dyspnoea. Physical
examination showed clubbing of the digits, an uncommon ﬁnding
in MPM. The ﬂow volume loop (spirometery) disclosed a mild
obstructive pattern .MPM and asbestosis usually demonstrates a
restrictive pattern. The clinical signiﬁcance of this pattern in this
patient is uncertain. On bronchoscopy for airway examination the
bronchial lavage retrieval yielded a ferruginised asbestos body
[Fig. 2.1]. Following a CT Scan of the chest [Figs. 1.1 and 1.2], the
diagnosis was established on an ultrasound-guided core biopsy of
the mediastinal mass that stained positive for mesothelial markers,
including calretinin [Fig. 2.2], AE1/AE3 cytokeratin [Fig. 2.3]and
epithelial membrane antigen[Fig. 2.4]. The patient had a high per-
formance status at the time of diagnosis, and was treated with
palliative chemotherapy, opioid analgesics and carbamezapine for0204, Pretoria, South Africa.
.
Ltd.Open access under CC BY-NC-ND neuropathic pain, but succumbed a year later to his disease
[Fig. 1.3].
Discussion
Reported cases of malignant pleural mesothelioma are rare, 3e
4/million a year in industrialised countries [2,3]. Only 10% report a
history of asbestos exposure, with a latency period of approxi-
mately 15 years [4,5,10]. The link between asbestos exposure and
MPM was ﬁrst reported in South Africa in 1960 [3,5]. Asbestos is a
common component of insulation, ceiling, rooﬁng vinyls cement
and automobile breaking material.
Chest pain is an important symptom and is usually neuronal or
somatic, due to intercostal nerve and localized invasion respec-
tively. Radiotherapy should not be used to treat nerve root pain as it
may cause tissue necrosis and further compression of intercostal
nerves [6]. Local invasion to the pericardium and spinalcord may
also occur. The common sights of spread are the hilar, mediastinal
and supra clavicular lymphnodes. Metastasis to bone may also
occur and miliary spread is occasionally apparent [Fig. 1.3] [4].
Asbestos bodies in BAL ﬂuid correlate with occupational expo-
sure [6]. Asbestos bodies are easily identiﬁed and quantiﬁed by
light microscopy; an asbestos body recovery of more than one Ab/
ml indicates a high probability of occupational exposure. Asbestos
bodies are asbestos ﬁbres that have been coated with an iron rich
proteinaceous concretion. Amphibole asbestos forms majority of
asbestos bodies and is more persistent in lung tissue than chryso-
lite. Greater than 8 AB/ml on BAL is strongly correlated with ma-
lignant mesothelioma or lung cancer [6]. The notion that some
ﬁbres are safer than others should be abandoned, as all asbestos are
ﬁbrogenic and carcinogenic [6,7].
CT is the ﬁrst line and most common imaging modality for the
evaluation of mesothelioma [Table 1].MRI and PET scan are useful
in delineating the extent of the disease, staging and guiding biopsylicense.
Table 1
Frequency of occurrence, sensitivity and speciﬁcities for malignant pleural disease
using CT scan.
Sensitivity (%) Speciﬁcity (%) Frequency
Pleural rind 41 100 Very common
Nodular thickening 51 94 Common
Parietal thickening 36 94 Common
Mediastinal pleural disease 56 88 Uncommon
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on DWI due to tumour deposits) sign on MRI has a high positive
predictive value for the diagnosis of MPM [8]. Immunohistochem-
istry markers are important for determining the tissue of origin inFig. 1.1. CT-chest coronal view Demonstrating mediastinal mass.
Fig. 1.2. post-contrast axial CT showing the tumour Compressing mediastinal
Structure.
Fig. 1.3. Chest X-ray a year later demonstrating extensive bilateral lung involvement
suggesting miliary spread.mesothelial cell (calretinin), and its malignant potential (EMA), and
AE1/3 cytorkeratin suggests invasion [3,4,9,10]. A speciﬁc known
marker for MPM has not been recognised; in general Calretinin,
keratin 5/6 and podoplanin are considered to be the positive
mesothelioma markers. Immunohistostaining helps distinguish
mesothelioma from adenocarcinoma; CEA and BerEp4 are the best
negative markers for distinguishing between adenocarcinoma and
mesothelioma. In challenging situations electron microscopy may
be necessary [4,9].
Malignant pleural mesothelioma is a highly aggressive and
treatment resistant tumour [11]. Median survival is 9 months from
time of diagnosis [2e4]. Molecular targeted therapies may yield
promising new treatment options but are still in its infancy andFig. 2.1. Feruginised asbestos body.
Fig. 2.3. Positive AE1/3 cytokeratin stain.
Fig. 2.2. Positive calretinin stain high magniﬁcation.
Fig. 2.4. Positive epithelial membrane antigen stain.
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chemotherapy and radiotherapy are needed to improve treatment
outcome and survival [12].
Conclusion
The anterior mediastinum is a common location for thymic
lesion, germ cell tumours, lymphomas and endocrine tumours inadults. Mesenchymal tumours localised to the anterior medias-
tinum compartment is rare in adults. Evidence is lacking for any
relation between platinum mining and the development of meso-
thelioma. MPM presenting in this location and in this fashion is
atypical. The pleura share an interface with the lung on both the
parenchymal and mediastinal sides. MPM can therefore present as
amasswith a sharp incomplete border that is frequently tapered on
either the parenchymal or mediastinal sides. CT scan has a poor
sensitivity and speciﬁcity for diagnosing mediastinal side MPM and
therefore a certain diagnosis can and must only be made by biopsy.Conﬂict of interest
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